230 related articles for article (PubMed ID: 23341100)
1. Gliomatosis cerebri: clinical characteristics, management, and outcomes.
Chen S; Tanaka S; Giannini C; Morris J; Yan ES; Buckner J; Lachance DH; Parney IF
J Neurooncol; 2013 Apr; 112(2):267-75. PubMed ID: 23341100
[TBL] [Abstract][Full Text] [Related]
2. Gliomatosis cerebri having a poor performance status without recurrence after radiotherapy: a single institutional experience.
Jung TY; Yoon MS; Kim YH; Jung S; Kim IY; Jang WY; Moon KS; Lee KH; Kim SK
Clin Neurol Neurosurg; 2015 Mar; 130():1-5. PubMed ID: 25569296
[TBL] [Abstract][Full Text] [Related]
3. Gliomatosis cerebri: molecular pathology and clinical course.
Herrlinger U; Felsberg J; Küker W; Bornemann A; Plasswilm L; Knobbe CB; Strik H; Wick W; Meyermann R; Dichgans J; Bamberg M; Reifenberger G; Weller M
Ann Neurol; 2002 Oct; 52(4):390-9. PubMed ID: 12325066
[TBL] [Abstract][Full Text] [Related]
4. Patterns of presentation and failure in patients with gliomatosis cerebri treated with partial-brain radiation therapy.
Kandula S; Saindane AM; Prabhu RS; Hanasoge S; Patel KR; Shu HK; Curran WJ; Crocker IR
Cancer; 2014 Sep; 120(17):2713-20. PubMed ID: 24845411
[TBL] [Abstract][Full Text] [Related]
5. Gliomatosis cerebri: a review of 22 cases.
Vates GE; Chang S; Lamborn KR; Prados M; Berger MS
Neurosurgery; 2003 Aug; 53(2):261-71; discussion 271. PubMed ID: 12925240
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Gliomatosis Cerebri: A Review of 15 Years.
George E; Settler A; Connors S; Greenfield JP
J Child Neurol; 2016 Mar; 31(3):378-87. PubMed ID: 26239491
[TBL] [Abstract][Full Text] [Related]
7. Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature.
Taillibert S; Chodkiewicz C; Laigle-Donadey F; Napolitano M; Cartalat-Carel S; Sanson M
J Neurooncol; 2006 Jan; 76(2):201-5. PubMed ID: 16200347
[TBL] [Abstract][Full Text] [Related]
8. Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study.
Ly KI; Oakley DH; Pine AB; Frosch MP; Chiou SH; Betensky RA; Pomerantz SR; Hochberg FH; Batchelor TT; Cahill DP; Dietrich J
Oncologist; 2019 Mar; 24(3):402-413. PubMed ID: 30097523
[TBL] [Abstract][Full Text] [Related]
9. Initial chemotherapy in gliomatosis cerebri.
Sanson M; Cartalat-Carel S; Taillibert S; Napolitano M; Djafari L; Cougnard J; Gervais H; Laigle F; Carpentier A; Mokhtari K; Taillandier L; Chinot O; Duffau H; Honnorat J; Hoang-Xuan K; Delattre JY;
Neurology; 2004 Jul; 63(2):270-5. PubMed ID: 15277619
[TBL] [Abstract][Full Text] [Related]
10. [Gliomatosis cerebri].
Sanson M; Napolitano M; Cartalat-Carel S; Taillibert S
Rev Neurol (Paris); 2005 Feb; 161(2):173-81. PubMed ID: 15798516
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors and Survival of Gliomatosis Cerebri: A Systematic Review and Meta-Analysis.
Georgakis MK; Tsivgoulis G; Spinos D; Liaskas A; Herrlinger U; Petridou ET
World Neurosurg; 2018 Dec; 120():e818-e854. PubMed ID: 30172970
[TBL] [Abstract][Full Text] [Related]
12. Gliomatosis cerebri: treatment results with radiotherapy alone.
Elshaikh MA; Stevens GH; Peereboom DM; Cohen BH; Prayson RA; Lee SY; Barnett GH; Suh JH
Cancer; 2002 Nov; 95(9):2027-31. PubMed ID: 12404298
[TBL] [Abstract][Full Text] [Related]
13. Gliomatosis cerebri: 20 years of experience at the Children's Hospital of Philadelphia.
Armstrong GT; Phillips PC; Rorke-Adams LB; Judkins AR; Localio AR; Fisher MJ
Cancer; 2006 Oct; 107(7):1597-606. PubMed ID: 16955507
[TBL] [Abstract][Full Text] [Related]
14. Gliomatosis cerebri in young patients' report of three cases and review of the literature.
Landi A; Piccirilli M; Mancarella C; Giangaspero F; Salvati M
Childs Nerv Syst; 2011 Jan; 27(1):19-25. PubMed ID: 20376465
[TBL] [Abstract][Full Text] [Related]
15. Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients.
Autran D; Barrie M; Matta M; Monserrat C; Campello C; Petrirena G; Boucard C; Padovani L; Loundou A; Appay R; Graillon T; Dufour H; Figarella-Branger D; Chinot O; Tabouret E
Anticancer Res; 2019 Feb; 39(2):1035-1041. PubMed ID: 30711992
[TBL] [Abstract][Full Text] [Related]
16. Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III Gliomas.
Divé I; Steidl E; Wagner M; Filipski K; Burger MC; Franz K; Harter PN; Bähr O; Fokas E; Herrlinger U; Steinbach JP
Oncology; 2021; 99(4):215-224. PubMed ID: 33472203
[TBL] [Abstract][Full Text] [Related]
17. Gliomatosis Cerebri Among Children and Adolescents: An Individual-Patient Data Meta-analysis of 182 Patients.
Georgakis MK; Tsivgoulis G; Pourtsidis A; Petridou ET
J Child Neurol; 2019 Jun; 34(7):394-401. PubMed ID: 30887873
[TBL] [Abstract][Full Text] [Related]
18. Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis.
Carroll KT; Hirshman B; Ali MA; Alattar AA; Brandel MG; Lochte B; Lanman T; Carter B; Chen CC
World Neurosurg; 2017 Jul; 103():186-193. PubMed ID: 28366748
[TBL] [Abstract][Full Text] [Related]
19. Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri.
Kaloshi G; Guillevin R; Martin-Duverneuil N; Laigle-Donadey F; Psimaras D; Marie Y; Mokhtari K; Hoang-Xuan K; Delattre JY; Sanson M
Neurology; 2009 Aug; 73(6):445-9. PubMed ID: 19667319
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.
Inoue T; Kumabe T; Kanamori M; Sonoda Y; Watanabe M; Tominaga T
Neurosurg Rev; 2010 Apr; 34(2):197-208. PubMed ID: 21301914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
